In a study of commonly used treatments for people with multiple sclerosis, both medical and behavioral interventions, and a ...

It's been one week since Wanda Lee-Ballou received University of Virginia (UVA) Health's first dose of Ocravus Zunovo – the ...

A recent study showed that both cognitive behavioral therapy (CBT) and the mild stimulant modafinil (Provigil) reduced MS ...

What used to take hours, we can now do in less than 30 minutes”: FDA OKs new treatment for people suffering from multiple ...

Oct. 2, 2024 — Researchers have found a potential new way to improve the treatment of multiple sclerosis (MS) using a novel combined therapy. The results build on two harmonized Phase I clinical ...

Researchers have found that combining tolerogenic dendritic cells with Dimethyl Fumarate improves treatment efficacy for ...

The COMBO-MS trial, reported in The Lancet Neurology by Tiffany Braley and colleagues,1 is the first pragmatic, randomised, controlled trial that compares head-to-head the benefits and harms of a ...

It is hoped the discovery by Edinburgh University can be adapted to treat humans after being tested on mice. A woman with ...

Sanofi stopped a Phase 2 study of oditrasertib in relapsing and progressive MS after it failed to lower blood NfL levels ...

UVA Health is making strides as among the first in the country to provide a new treatment option with a dose of Ocrevus ...

As columnist Ben Hofmeister and his wife celebrate their 15th wedding anniversary, he reflects on how MS has shaped their marriage.

In a study of commonly used treatments for multiple sclerosis, both medical and behavioral interventions, and a combination of the two, resulted in significant improvements in fatigue. Researchers say ...